Skip to main content
. 2021 Apr 12;16(4):e0249179. doi: 10.1371/journal.pone.0249179

Table 1. In vitro dissolution data of 1 mg larazotide acetate of a delayed release formulation in 6 capsules.

Sampling time points (minutes) Time in GIT (minutes) Average (±SD) Dissolution (%) of 1 mg LA (n = 6)
Simulated gastric media (Stomach) 0 0 0
30 30 0
60 60 0.1 ± 300
120 120 0.7 ± 85.7
Simulated intestinal media (Small intestine) 15 135 1.4 ± 42.9
30 150 39.7 ± 11.4
45 165 41.2 ± 14.4
60 180 42.8 ± 12.6
90 210 79.1 ± 18.3
120 240 93.7 ± 2.4
180 300 93.7 ± 2.5

Times (minutes) in small intestine were back calculated by adding 120 minutes to sampling time point respectively. LA: larazotide acetate, GIT: gastrointestinal tract, SD: standard deviation